Association of Maternal Hemoglobin Concentration With Neonatal Outcomes in Deliveries: A Prospective Cohort Study.
- 1Maternal-Fetal and Neonatal Research Center, Family Health Research Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
- 2Center for Orthopedic Trans-Disciplinary Applied Research, Tehran University of Medical Sciences, Tehran, Iran.
Abstract
Objective
Maternal hemoglobin concentration during pregnancy is a key indicator of placental-fetal oxygen delivery and may influence neonatal outcomes. Despite existing evidence, prospective cohort data in the Iranian population remain limited. This study aimed to investigate the association between maternal hemoglobin concentration and neonatal outcomes while controlling for potential confounding factors.Materials and methods
This prospective cohort study was conducted over a six-month period. A total of 263 eligible mother-neonate pairs were included in the analysis. Maternal hemoglobin concentration was measured at 28 weeks of gestation, and participants were categorized into two groups: Hb < 11 g/dL (anemia) and Hb ≥ 11 g/dL. Neonatal outcomes were investigated in two groups. Statistical analyses were performed using independent t-tests, chi-square tests, and univariate and multivariate linear and logistic regression models, adjusting for gestational age, mode of delivery, parity, maternal conditions, and iron supplementation.Results
The incidence of RDS was calculated 56% (33 neonates) and 26% (48 neonates) in mothers with anemia and normal, respectively. Neonates born to mothers with Hb ≥ 11 g/dL had a significantly lower risk of RDS compared with those born to anemic mothers (adjusted OR = 0.64; P < 0.01). No significant association was observed between maternal anemia and either birth weight or birth length in multivariate analysis.Conclusion
Adequate maternal hemoglobin concentration is associated with a reduced risk of neonatal RDS. Timely screening and appropriate management of maternal anemia may play an important role in improving neonatal respiratory outcomes.
Related
- The relationship between hemoglobin concentration in the third-trimester and gestational age, birth weight of newborns: stratified analysis based on maternal age.
- The association between prenatal maternal selenium concentration and mental health in early childhood, a mother-child cohort study
- Heterogeneous association between maternal haemoglobin concentration and child haemoglobin levels: a quantile regression analysis using multi-country nationally representative data.
- Increased mean corpuscular hemoglobin concentration : A case report as an early clue of chronic severe hyponatremia
- The relationship between hemoglobin concentration and mortality in patients receiving venovenous extracorporeal membrane oxygenation support: a single-center retrospective cohort study
BibTeX
@article{sahebi2026association,
title = {{Association of Maternal Hemoglobin Concentration With Neonatal Outcomes in Deliveries: A Prospective Cohort Study.}},
author = {Leyla Sahebi and Hossein Dalili and Mazyar Babagoli and Atefeh Sabbagh},
journal = {Journal of family \& reproductive health},
year = {2026},
month = jun,
doi = {10.18502/jfrh.v20i2.22615},
url = {https://europepmc.org/article/MED/42924315},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Association of Maternal Hemoglobin Concentration With Neonatal Outcomes in Deliveries: A Prospective Cohort Study.
AU - Leyla Sahebi
AU - Hossein Dalili
AU - Mazyar Babagoli
AU - Atefeh Sabbagh
PY - 2026
DA - 2026/06/01
JO - Journal of family & reproductive health
DO - 10.18502/jfrh.v20i2.22615
UR - https://europepmc.org/article/MED/42924315
AB - Objective Maternal hemoglobin concentration during pregnancy is a key indicator of placental-fetal oxygen delivery and may influence neonatal outcomes. Despite existing evidence, prospective cohort data in the Iranian population remain limited. This study aimed to investigate the association between maternal hemoglobin concentration and neonatal outcomes while controlling for potential confounding factors.Materials and methods This prospective cohort study was conducted over a six-month period. A total of 263 eligible mother-neonate pairs were included in the analysis. Maternal hemoglobin concentration was measured at 28 weeks of gestation, and participants were categorized into two groups: Hb < 11 g/dL (anemia) and Hb ≥ 11 g/dL. Neonatal outcomes were investigated in two groups. Statistical analyses were performed using independent t-tests, chi-square tests, and univariate and multivariate linear and logistic regression models, adjusting for gestational age, mode of delivery, parity, maternal conditions, and iron supplementation.Results The incidence of RDS was calculated 56% (33 neonates) and 26% (48 neonates) in mothers with anemia and normal, respectively. Neonates born to mothers with Hb ≥ 11 g/dL had a significantly lower risk of RDS compared with those born to anemic mothers (adjusted OR = 0.64; P < 0.01). No significant association was observed between maternal anemia and either birth weight or birth length in multivariate analysis.Conclusion Adequate maternal hemoglobin concentration is associated with a reduced risk of neonatal RDS. Timely screening and appropriate management of maternal anemia may play an important role in improving neonatal respiratory outcomes.
SN - 1735-8949
SN - 1735-9392
ER -